Fund Evaluator:
Nomura Focused Large Growth ETF (LRGG)
Follow This Fund
Equity
Global Asset Class
U.S. Equity
Fund Group
Large Growth
Category
$0.000
NAV (as of )
$0.00
Minimum Initial
0.44% B
Expense Ratio
$296 Mil
Assets
Open
Status
na
12b-1 Fee
0.16%
TTM Yield
0.00%
Max Load
20%
Portfolio Turnover
Best Performing in Large Growth Over the Last Year
| 39.6% | Tanaka Growth (TGFRX) |
| 35.2% | Fidelity Advisor OTC Z (FOTJX) |
| 35.1% | Fidelity OTC (FOCPX) |
| 34.8% | Chase Growth N (CHASX) |
| 27.3% | Fidelity Advisor Focused Stock Z (FSFOX) |
Data as of 7/31/2026
5.0% A
1-Mo Return
3.8% B
3-Mo Return
-2.4% F
YTD Return
-2.8% F
1-Yr Return
na
3-Yr Return
na
5-Yr Return
na
Category Risk Index
na
Total Risk Index
Fund Details
Fund Family
Nomura
Inception Date
5/14/2024
Share Class Type
Equity Investment Style
Large-Cap
Growth
Bond Investment Style
na
Socially Responsible Fund
No
Index Fund
No
Benchmark Index
N/A: 100%
Additional Fund Details
Nomura Focused Large Growth ETF Overview
LRGG Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| LRGG Return (NAV) | 5.0% | 3.8% | -2.8% | na | na | na |
| LRGG Grade | A | B | F | na | na | na |
| +/- Category | 8.1% | 2.1% | -11.9% | na | na | na |
| Large Growth Avg | -3.1% | 1.7% | 9.1% | 18.1% | 8.7% | 15.4% |
| LRGG Tax Cost Ratio | na | na | 0.1% | na | na | na |
LRGG Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| LRGG Return (NAV) | -2.4% | 7.7% | na | na | na | na | na | na | na | na | na |
| LRGG Grade | F | F | na | na | na | na | na | na | na | na | na |
| +/- Category | -6.1% | -8.0% | na | na | na | na | na | na | na | na | na |
| Large Growth Avg | 3.7% | 15.7% | 29.7% | 38.9% | -32.1% | 20.4% | 42.3% | 33.2% | -0.7% | 29.8% | 2.7% |
| Risk Measures | |
| Standard Deviation: | na |
| Total Risk Index: | na |
| Category Risk Index: | na |
| Category Risk Grade: | |
| Beta: | na |
| R-Squared: | na |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Large-Cap Growth |
| Bond Investment Style: | na |
| Yield: | 0.2% |
| Dividend Distribution: | Annually |
| Cap Gains Distribution: | Annually |
| Total Assets: | $296 Mil |
| Fund Total Assets: | $ 297 Mil |
| Share Class Type: | |
| Portfolio Turnover: | 20% |
Management Team
| Number of Managers: 2 | |||
| Longest Tenure: 2.2 years | |||
| Average Tenure: 2.2 years | |||
| Managers (Year): Angermeier Bradley (2024), Klapmeyer Bradley (2024) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 22 |
| % in Top 10 Holdings: | 70.8% |
| Fund is Non-Diversified: | Yes |
| % in Foreign Issues: | 9.0% |
Portfolio Allocation |
|
| Domestic Stock: | 90.6% |
| Foreign Stock: | 9.0% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 0.4% |
Purchase Information
| Fund Family: | Nomura |
| Phone Number: | 844-469-9911 |
| Website: | global.nomuraassetmanagement.com/investments/etf |
| Status: | Open |
| Inception Date: | May 14, 2024 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | na |
Expenses and Fees | |
| Expense Ratio (%): | 0.44% ( Rating : Avg ) |
| Category Average Expense Ratio (%): | 0.96% |
| Share Class: | Nomura Focused Large Growth ETF |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.